Related Experiment Video
Updated: Jun 5, 2026

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Usefulness of the serum lactate concentration for predicting mortality in acute beta-blocker poisoning
Bruno Mégarbane1, Nicolas Deye, Isabelle Malissin
1Medical and Toxicological Critical Care Department, Lariboisiére Hospital, Paris-Diderot University, 75010, Paris, France. bruno-megarbane@wanadoo.fr
Context:
Serum lactate measured in the emergency department was recently assessed as an excellent prognosticator of drug-overdose fatality, with the optimal lactate cutoff point being 3.0 mmol/L. However, lactate's role has never been specifically studied in beta-blocker poisonings.
Objective:
We aimed to evaluate the ability of lactate concentrations to predict outcome (survival versus death) in beta-blocker poisoning.
Methods:
We conducted an 8-year retrospective study for all symptomatic beta-blocker poisonings admitted to our toxicological intensive care unit (ICU). Serum lactate concentrations were measured in 110 patients and final outcomes of survival or death recorded.
Results:
Lactate concentrations were 1.79 mmol/L [0.8-5.6] (median, 10-90% percentiles) and peak values of 1.9 mmol/L [0.9-9.5] (p < 0.0001). Nine patients (8%) died in the ICU. Admission serum lactate concentrations differed significantly between survivors and fatalities (p = 0.0008). Four patients (44% of the non-survivors) died in the ICU despite lactate concentrations lower than 3.0 mmol/L. The diagnostic characteristics of the 3.0 mmol/L selected lactate cutoff point were 55% sensitivity and 80% specificity.
Conclusion:
Serum lactate elevation in beta-blocker poisoning is relatively mild on admission despite the presence of significant cardiovascular symptoms. Even if raised in severe poisonings and alone correlate well with prognosis, lactate concentration is not an absolute predictor of beta-blocker-overdose fatality.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Coronary Syndrome III: Diagnostic Studies
Pharmacodynamic Models: Logarithmic Concentration–Effect Model
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance